Final Report - ARTEMIP (The safety pharmacology of Artemisinins when used to reverse pathophysiology of malaria in pregnancy)
Project ID: 200805Funded under: FP7-HEALTH
This is the final report for the ARTEMIP project which received funding under the European Commission (EC)'s Seventh Framework Programme (FP7). ARTEMIP's main aim was to gain an understanding of the safety pharmacology of artemisinin antimalarials in pregnancy by elucidating the mechanisms of toxicity and to inform recommendations on the risk-benefit balance in the first trimester of pregnancy in humans. The report includes an executive summary providing an overall overview of the project and goes on explaining the concept and analysing further its specific objectives. The report also covers a summary description of the work package achievements and closes with the results' potential impact.
Download application/zip (141406)
Record Number: 15303 / Last updated on: 2013-01-18